Limerick BioPharma, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile by GlobalData

VIEWS: 0 PAGES: 14

Limerick BioPharma, Inc. (Limerick) is a privately held bio-pharmaceutical company which is engaged in the development of pharmaceuticals with attenuated tissue specific toxicity. The compounds offered by the company minimizes toxic side effects at non-targeted vulnerable organs and tissue while maintaining or enhancing a drug’s desired effects. Limerick is developing compounds for the treatment of metabolic diseases such as hyperglycemia and hypercholesteremia. The company's technology platform cellular transporter pump activators has the capability of decreasing drug and unwanted chemical exposure to non-targeted organs and tissues. The product pipeline of the company includes LIM-5310 and LIM-0705 for immunosuppression; LIM-0744, LIM-5310, LIM-0741 and LIM-5662 for pain; and LIM-0746 for cholesterol and diabetes. In addition, it also offers products for acute, chronic and drug induced endorinopathy. Its products are used in a range of therapeutic drug classes including immunosuppressants, selective estrogens receptor modulators, immunomodulators, opioids, and psychotropics. Recently, the company has announce positive results of a Phase 1a trial for its lead compound, LIM-0705. Limerick is headquartered in South San Francisco, California, the US.

More Info
									                         Limerick BioPharma, Inc. - Pharmaceuticals & Healthcare - Deals and
                                                   Alliances Profile
       Reference Code: GDPH140766D                                                                                                             Publication Date: JAN 2013

      Company Overview                                                                                        Key Facts
      Limerick BioPharma, Inc. (Limerick) is a privately held bio-pharmaceutical company
                                                                                                              Limerick BioPharma, Inc., Pharmaceuticals &
      which is engaged in the development of pharmaceuticals with attenuated tissue
                                                                                                              Healthcare, Key Facts
      specific toxicity. The compounds offered by the company minimizes toxic side
      effects at non-targeted vulnerable organs and tissue while maintaining or enhancing                      Web Address                          www.limerickbio.com
      a drug’s desired effects. Limerick is developing compounds for the treatment of
                                                                                                               Revenue (US$ million)                            NA
      metabolic diseases such as hyperglycemia and hypercholesteremia. The company's
      technology platform cellular transporter pump activators has the capability of                           Number of Employees                                        50
      decreasing drug and unwanted chemical exposure to non-targeted organs and                                GlobalData
      tissues.

      Financial Deals Landscape
        Limerick BioPharma, Inc., Pharmaceuticals & Healthcare, Deals                     Limerick BioPharma, Inc., Pharmaceuticals & Healthcare,
        by Type, 2007 to YTD 2013                                                         Deals By Year, 2007 to YTD 2013


                                                                                                                                   2
                                                                                                          2

                                                                                           No. of Deals
                                                                                                                         1
                                                                                                          1


                                                                                                                 0                         0        0     0        0
                                                                                                          0
                                                                                                               2007     2008      2009   2010    2011    2012     YTD
                                                                                                                                                                  2013


                                                                                          Note: Deals include all announced pharmaceuticals & healthcare deals
         Note: Deals include all announced pharmaceuticals & healthcare deals from
                                                                                          from 2006 onwards, GlobalData
         2006 onwards, GlobalData


         Limerick BioPharma, Inc., Pharmaceuticals & Healthcare,                          Limerick BioPharma, Inc., Pharmaceuticals & Healthcare,
         Deals By Region, 2007 to YTD 2013                                                Deals By Therapy Area, 2007 to YTD 2013


                         3                                                                                               3                 3
          No. of Deals




                                                                                                          3
                               3
                                                                                           No. of Deals




                         2
                                                                                                          2
                         1
                                                                                                                                                          1
                                        0         0        0         0                                    1
                         0
                             North    Asia-     Europe   Middle   South
                             Americ   Pacific             East     and                                    0
                               a                          and     Central                                             Metabolic        Toxicology       Central
                                                         Africa   Americ                                              Disorders                         Nervous
                                                                    a                                                                                   System



         Note: Deals include all announced pharmaceuticals & healthcare deals             Note: Deals include all announced pharmaceuticals & healthcare deals
         from 2006 onwards, GlobalData                                                    from 2006 onwards, GlobalData




Limerick BioPharma, Inc. - Pharmaceuticals & Healthcare - Deals                                                                                 Reference Code: GDPH140766D
and Alliances Profile
Source : www.globalcompanyintelligence.com                                                                                                                                     Page 1
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
       Table of Contents
       Table of Contents ............................................................................................................................................................................... 2
          List of Tables .................................................................................................................................................................................. 3
          List of Figures ................................................................................................................................................................................. 3
       Limerick BioPharma, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013 .......................................................... 3
       Limerick BioPharma, Inc., Pharmaceuticals & Healthcare Deals By Type, 2007 to YTD 2013 .......................................................... 5
       Limerick BioPharma, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2007 to YTD 2013 ...................................................... 6
       Limerick BioPharma, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2007 to YTD 2013............................................ 7
       Limerick BioPharma, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2007 to YTD 2013 ....................................................... 8
       Limerick BioPharma, Inc., Pharmaceuticals & Healthcare, Deal Details ............................................................................................ 9
          Venture Financing........................................................................................................................................................................... 9
             Limerick BioPharma Raises $15 Million In Series C Financing Round ....................................................................................... 9
             Limerick BioPharma Raises $1.5 Million In Venture Financing ................................................................................................. 10
             Limerick BioPharma Raises $15.2 Million In Venture Financing ............................................................................................... 11
       Limerick BioPharma, Inc. - Key Competitors .................................................................................................................................... 12
       Locations And Subsidiaries .............................................................................................................................................................. 13
          Head Office ................................................................................................................................................................................... 13
       Appendix .......................................................................................................................................................................................... 14
          Methodology ................................................................................................................................................................................. 14
          About GlobalData ......................................................................................................................................................................... 14
          Contact Us .................................................................................................................................................................................... 14
          Disclaimer ...........................................................................................................
								
To top